Searchable abstracts of presentations at key conferences in endocrinology

ea0055p10 | Poster Presentations | SFEEU2018

Multiple bone tumours in primary hyperparathyroidism – not so brown after all

Calvo-Latorre Julia , Lawrence Victor , Arnez Lorena

Case history: A 28 year-old male of British origin was referred with a one-year history of a left-sided chest mass and an abnormal chest X-ray. He was otherwise fit and well, had a past medical history of vitiligo and had no relevant family history. His physical examination revealed some hypopigmented spots on his skin, several tattoos across his back and a firm mass on his left upper chest, which was mildly tender on palpation. He had no other palpable masses.<p class="ab...

ea0090ep1135 | Late Breaking | ECE2023

Doege-Potter Syndrome, cause of paraneoplastic hypoglycaemia in a patient with a Solitary Fibrous Tumour: A Case Report

Sheikh Anum , Calvo Latorre Julia , Kehinde Razak

Background: Non-islet-cell tumour hypoglycaemia (NICTH) is a rare paraneoplastic syndrome caused by an extra pancreatic tumour(1). Solitary fibrous tumour (SFT), amongst other tumours, is one of the rare causes of NICTH. We report a case of NICTH who presented with recurrent hypoglycaemias and was identified to have a fibrous tumour as part of the work up for his symptomatic hypoglycaemias.Case Summary: A 75-year male had presented to the emergency depar...

ea0090p548 | Adrenal and Cardiovascular Endocrinology | ECE2023

Pheochromocytomas in patients with Parkinson’s disease: a diagnostic and therapeutic challenge

Calvo Latorre Julia , Patel Bharat , Sheikh Anum , Radia Florika , Ali Tauni Rahat

Dopamine agonists can falsely elevate plasma and urinary metanephrines, thus making the diagnosis of pheochromocytomas in patients taking these medications challenging. We present the case of an 80-year-old female care home resident with a background of hypertension, ParkinsonÂ’s disease (PD), dementia and pernicious anaemia. She presented with weight loss, unilateral leg swelling and abdominal distension. A computed tomography (CT) showed a 5.6 cm heterogeneously enhancin...

ea0094p391 | Thyroid | SFEBES2023

Alemtuzumab-induced Graves’ disease management in pregnancy

Calvo Latorre Julia , Kostoula Melina , Galliford Thomas , Mehta Anku , Sheikh Anum , Radia Florika , Ezenwa Chima

Alemtuzumab is a monoclonal antibody used in the treatment of relapsing-remitting multiple sclerosis (RRMS). Thyroid dysfunction is a common side effect. Alemtuzumab induced GravesÂ’ disease (AIGD) is notable for its fluctuating and unpredictable course. We present the case of two women with RRMS who required total thyroidectomy to manage AIGD and were followed up in our antenatal endocrine clinic during their pregnancy. The first patient is a 31-year-old lady who develope...